Evidence map›Paper›PMID 40893562›Full record

ArticleQuantitative imaging in medicine and surgery2025

Comparison of [

Ji Wu, Yang Meng, Qinyao Li, Chunyin Zhang, Guohao Jiang

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. European journal of nuclear medicine and molecular imaging · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ji WuDepartment of Nuclear Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yang MengDepartment of Nuclear Medicine, Institute of Traditional Chinese Medicine of Sichuan Academy of Chinese Medicine Sciences (Sichuan Second Hospital of Traditional Chinese Medicine), Chengdu, China.
Qinyao LiDepartment of Nuclear Medicine, Institute of Traditional Chinese Medicine of Sichuan Academy of Chinese Medicine Sciences (Sichuan Second Hospital of Traditional Chinese Medicine), Chengdu, China.
Chunyin ZhangDepartment of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Guohao JiangDepartment of Nuclear Medicine, Institute of Traditional Chinese Medicine of Sichuan Academy of Chinese Medicine Sciences (Sichuan Second Hospital of Traditional Chinese Medicine), Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bone metastases of lung cancer typically indicate disease progression and poor prognosis. Early and accurate detection is crucial for staging, treatment planning, and prognostic evaluation. This study aimed to compare the diagnostic value of gallium 68-labeled fibroblast-activation protein inhibitor-04 ([ Methods: A retrospective analysis was conducted on patients with pathologically confirmed lung cancer and clinically suspected bone metastases. These patients underwent both [ Results: A total of 25 lung cancer patients were included in the study, with nine confirmed cases and 133 lesions of bone metastases. At the patient level, there were no statistically significant differences in the detection rate, sensitivity, specificity, positive predictive value, negative predictive value, or accuracy between [ Conclusions: Compared to [

Indexed as

Bone metastasiscomputed tomography (CT)fibroblast-activation protein inhibitor (FAPI)fluorodeoxyglucose (FDG)positron-emission tomography (PET)

Identifiers

PMID40893562
PMCPMC12397704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.